Allen AM, Kamath PS, Larson JJ, et al. Cardiovascular Risk in NAFLD- Not an Equal Opportunity: Implications for Women’s Health. AASLD 2017, abstract 55.
Advies over sluisplaatsing talquetamab, epcoritamab en tislelizumab
sep 2023 | Lymfoom, Maag-darm-leveroncologie, MM